Media Summary: This presentation explained the concept of This webinar led by TransCelerate's Embedded Pragmatic This presentation emphasized the importance of increasing diversity in

Redi 2024 D1s04 Selective Safety Data Collection In Clinical Trials - Detailed Analysis & Overview

This presentation explained the concept of This webinar led by TransCelerate's Embedded Pragmatic This presentation emphasized the importance of increasing diversity in This presentation introduced CDER's Center for Learn directly from the FDA's regulatory experts in The keynote provided an overview to updates and cutting-edge insight on novel artificial intelligence (AI),

This presentation discussed FDA's perspective on This presentation provided a comprehensive overview of FDA CDER's NextGen Portal and compared functionality before and ... This presentation explored the transformation of Learn the essential principles behind rigorous This presentation explored how electronic technologies are revolutionizing The first of two Q&A discussion panels for day one of the

Explore the critical importance of including diverse populations in

Photo Gallery

REdI 2024 | D1S04 - Selective Safety Data Collection in Clinical Trials
In Conversation with FDA: Advancing Selective Safety Data Collection in Pragmatic Trials
Introduction to ICH E19:  Selective Collection of Safety Data in Clinical Trials
REdI 2024 | D1S08 - Diversity in Clinical Trials: Drug Trials Snapshots Perspective
REdI 2024 | D1S05 - The CDER Center for Clinical Trial Innovation (C3TI)
CITC 2024 – D1S05 – Safety Considerations in Clinical Drug Development
CDRH - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products
REdI 2024 | D1S02 – Keynote Address
CITC 2024 – D3S01 – Achieving Fit-for-Purpose Clinical Trial Quality
CBER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products
SCDM - Year in Review 2024
REdI 2024 | D2S03-2 - FDA CDER NextGen Portal
Sponsored
Sponsored
View Detailed Profile
REdI 2024 | D1S04 - Selective Safety Data Collection in Clinical Trials

REdI 2024 | D1S04 - Selective Safety Data Collection in Clinical Trials

This presentation explained the concept of

In Conversation with FDA: Advancing Selective Safety Data Collection in Pragmatic Trials

In Conversation with FDA: Advancing Selective Safety Data Collection in Pragmatic Trials

This webinar led by TransCelerate's Embedded Pragmatic

Sponsored
Introduction to ICH E19:  Selective Collection of Safety Data in Clinical Trials

Introduction to ICH E19: Selective Collection of Safety Data in Clinical Trials

Facilitating efficiencies in

REdI 2024 | D1S08 - Diversity in Clinical Trials: Drug Trials Snapshots Perspective

REdI 2024 | D1S08 - Diversity in Clinical Trials: Drug Trials Snapshots Perspective

This presentation emphasized the importance of increasing diversity in

REdI 2024 | D1S05 - The CDER Center for Clinical Trial Innovation (C3TI)

REdI 2024 | D1S05 - The CDER Center for Clinical Trial Innovation (C3TI)

This presentation introduced CDER's Center for

Sponsored
CITC 2024 – D1S05 – Safety Considerations in Clinical Drug Development

CITC 2024 – D1S05 – Safety Considerations in Clinical Drug Development

Discover the critical

CDRH - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

CDRH - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

Learn directly from the FDA's regulatory experts in

REdI 2024 | D1S02 – Keynote Address

REdI 2024 | D1S02 – Keynote Address

The keynote provided an overview to updates and cutting-edge insight on novel artificial intelligence (AI),

CITC 2024 – D3S01 – Achieving Fit-for-Purpose Clinical Trial Quality

CITC 2024 – D3S01 – Achieving Fit-for-Purpose Clinical Trial Quality

This presentation discussed FDA's perspective on

CBER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

CBER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

Learn directly from the FDA's regulatory experts in

SCDM - Year in Review 2024

SCDM - Year in Review 2024

SCDM is proudly advancing advancing

REdI 2024 | D2S03-2 - FDA CDER NextGen Portal

REdI 2024 | D2S03-2 - FDA CDER NextGen Portal

This presentation provided a comprehensive overview of FDA CDER's NextGen Portal and compared functionality before and ...

29 Schilsky - Optimizing Safety Data Collection in Cancer Clinical Trials

29 Schilsky - Optimizing Safety Data Collection in Cancer Clinical Trials

2/12/2013 - Optimizing

CITI Program Webinar Demo - FDA IND Safety Reporting for Clinical Trial Investigations

CITI Program Webinar Demo - FDA IND Safety Reporting for Clinical Trial Investigations

IND

REdI 2024 | D2S06 - Reimagining Clinical Research: The Transformation of Trial Design & Conduct

REdI 2024 | D2S06 - Reimagining Clinical Research: The Transformation of Trial Design & Conduct

This presentation explored the transformation of

CITC 2024 – D1S02 – Basics of Clinical Trial Design

CITC 2024 – D1S02 – Basics of Clinical Trial Design

Learn the essential principles behind rigorous

CITC 2024 – D2S05 – Innovative Approaches to Clinical Trials

CITC 2024 – D2S05 – Innovative Approaches to Clinical Trials

This presentation explored how electronic technologies are revolutionizing

CITC 2024 – D1S04 – Q&A Discussion Panel 1

CITC 2024 – D1S04 – Q&A Discussion Panel 1

The first of two Q&A discussion panels for day one of the

CITC 2024 – D1S06 – Specific Populations in Clinical Trials

CITC 2024 – D1S06 – Specific Populations in Clinical Trials

Explore the critical importance of including diverse populations in